Symptomatic catheter related thrombosis (CRT) occurs in 4%–8% of cancer patients. The
mean incidence of CRT, detected either by echography or Doppler ranges between 12 and …

Background A reliable central venous access device is a cornerstone in the treatment of
cancer. Both peripherally inserted central catheters (PICC) and totally implanted chest ports …

Background A peripherally inserted central catheter (PICC) is often necessary for patients
receiving chemotherapy, but there is a risk of PICC-related venous thrombosis (VT). We …

Objectives Totally implantable central venous access ports (port-a-caths) are increasingly
used for the safe administration of chemotherapy; however, their use is associated with …

Background Despite being a significant management decision in clinical or nursing practice,
there is limited understanding of the preferences regarding risks, benefits, costs, and other …

to be both culturally syntonic and feasible for the global scope and scale. Access to
bereavement support, and higher order mental health interventions as needed, is further …

Introduction Central line‐associated bloodstream infection (CLABSI) is a public health
problem that harms patients' outcomes and healthcare costs, especially in susceptible …

Background Catheter‐related venous thrombosis (CRVT) is a severe complication of home
parental nutrition. Although primary prevention of CRVT is crucial, there is no consensus on …

Purpose: Retrospective studies suggest that it may be safe to extend the maintenance
flushing interval of implanted ports from once every month, as recommended by the …

Chemotherapycomplicatedwithinfectioninac… (AML) hasbeenahottopicin
hematologyresearch. ChemotherapyisthemaintreatmentforAML, andtheadverseeventscausedbychemothera …